USPTO serial 88935304
CLINWEB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 20, 2021
- Examiner
- GERMICK JR., EDWARD JOSEPH
- Law office
- TMO LAW OFFICE 131
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CLINWEB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Millcreek, UT, US
Millcreek, UT, US
Millcreek, UT, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher T. McNeill
2261 E 3300 SMillcreek, UT 84109United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; database management in the nature of management of the data and information generated in medical clinical trials and research | ACTIVE | Nov 24, 2020 |
| 042 | Providing temporary use of on-line non-downloadable software for enabling clinical researchers to collect data on their subjects; Software as a service (SaaS) featuring software for use in managing data and information in the field of medical clinical trials and research; Providing online non-downloadable software for clinical trial monitoring and events capture in the nature of gathering, organizing, and classifying information and data generated in medical clinical trials and research; Providing online non-downloadable software for clinical data capture, management and reporting of medical clinical trials and research results; Providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and research; planning, development and project management of medical clinical trials and research; Clinical trial randomization and trial supply management, namely, the management of data and information generated in medical clinical trials and research to be used in medical clinical trials for patient tracking and management, for patient randomization and enrollment, for pharmaceutical supply management and dosing, logistics management, and for material inventory and supply management; Clinical trial monitoring and events capture in the nature of the gathering and organizing the information and data generated in medical clinical trials and research; Clinical data capture, management and reporting of the results of medical clinical trials and research; Providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and research; Providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and research, namely, for clinical trial protocol development, statistical analysis plan development, clinical trial planning and management, clinical trial user and learning management, clinical trial randomization and trial supply management, clinical trial monitoring and events capture, and clinical data capture, management and reporting; Providing online-non downloadable software to assist others in designing protocols for drug studies | ACTIVE | Feb 28, 2015 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pentara Corporation
- Other trademarks owned by Pentara Corporation
- Other trademarks owned by Pentara Corporation
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named CLINWEB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 1, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 1, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 1, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 20, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 4, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 4, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 14, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 27, 2021 | AAUA | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | — |
| Mar 26, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 26, 2021 | IUAA | USE AMENDMENT ACCEPTED | — |
| Mar 6, 2021 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Mar 6, 2021 | IUAF | USE AMENDMENT FILED | — |
| Mar 5, 2021 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Mar 4, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 4, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 1, 2021 | ALIE | ASSIGNED TO LIE | — |
| Nov 30, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 14, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 24, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 24, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 24, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 22, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 22, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 22, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 27, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 15, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 30, 2020 | NWAP | NEW APPLICATION ENTERED | — |